Abstract
Steroid, thyroid, and vitamin hormones are known to exert profound regulatory control over complex gene networks. Many, if not all, of these actions occur at the level of the cellular genome (O’Malley, 1992; Yamamoto, 1985). The products of these modulated genes control processes essential to cellular growth and differentiation as well as influence mechanisms integral to the maintenance of intracellular and extracellular homeostasis. The actions of these signals are mediated by unique intracellular receptors (Jensen et al, 1968; Jensen and DeSombre, 1972). Indeed, the presence of these receptor proteins in cells and tissues represents a principal determinant of response to a particular hormone. These soluble signal-transducing proteins are members of an enlarging gene family of latent transcription factors that acquire unique gene regulating capacities upon activation by their respective hormonal ligands (Evans, 1988). While hormone interaction has been well characterized, the events that follow association of the ligand with its receptor remain less well understood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baker AR, McDonnell DP, Hughes MR, Crisp TM, Mangesldorf DJ, Haussler MR, Pike JW, Shine J and O’Malley BW (1988): Cloning and expression of full length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85: 3294–3298.
Beato M (1989): Gene regulation by steroid hormones Cell 5: 335–344.
Burmester JK, Maeda N and DeLuca HF (1988): Isolation and expression of rat 1,25-dihydroxyvitamin D receptor cDNA. Proc Natl Acad Sci USA 85: 1005–1009.
Bumside J, Darling DS and Chin WW (1990): A nuclear factor that enhances binding of thyroid hormone receptors to a thyroid hormone response element. J Biol Chem 265: 2500–2504.
Celeste AJ, Rosen V, Buecker JL, Kriz R, Wang EA and Wozney JM (1986). Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J 5: 1885–1890.
de The H, del Mar Vivanco-Ruiz NM, Tiollais P, Stunnenberg H and Dejean A (1990): Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343: 177–180.
Delmas PD, Stenner D, Wahmer HW, Mann KG and Riggs BI (1973): Assessment of bone turnover in post menopausal osteoporosis by measurement of serum bone gla-protein. J Clin Invest 71: 1316–1323.
Demay MB, Gerardi JM, DeLuca HF and Kronenberg HM (1990): DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 87: 369–373.
Diamond MI, Miner JN, Yoshinaga SK and Yamamoto KR (1990): Transcription factor interactions: selectors or positive or negative regulation from a single DNA element. Science 249: 1266–1272.
Evans RM (1988): The steroid and thyroid hormone receptor superfamily. Science 240: 889–895.
Fawell WE, Lees JA, White R and Parker MG (1990): Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60: 953–962.
Freedman LP, Luisi BF, Korszun ZR, Basavappa R, Sigler PB and Yamamoto KR (1988): The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 334: 543–546.
Gerstenfeld LC, Chipman SD, Glowacki J and Lian JB (1986): Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 122: 49–60.
Glass CK, Franco R, Weinberger C, Albert VR, Evans RM and Rosenfeld MG (1988): A c-erb A binding site in rat growth hormone gene mediates trans-activation by thyroid hormone. Nature 329: 738–741.
Glass CK, Devary OV and Rosenfeld MG (1990): Multiple cell type-specific proteins differentially regulate target sequence recognition by the alpha retinoic acid receptor. Cell 63: 729–736.
Glowacki J and Lian JB (1989): Impaired recruitment of osteoclast progenitors by osteocalcin-deficient bone implants. Cell Diff 21: 247–254.
Gundberg CM, Lian JB, Gallop PM and Steinberg J J (1983): Urinary γ-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget’s disease. J Clin Endocrinol Metab 57: 1221–1225.
Hard T, Kellenbach E, Boelens R, Maler B, Dahlman K, Freedman LP, Carlstedt-Duke J, Yamamoto KR, Gustafsson J-A and Kaptein R (1990): Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249: 157–160.
Hauschka PV, Lian JB and Gallop PM (1975): Direct identification of the calcium binding amino acid g-carboxyglutamate in mineralized tissues. Proc Natl Acad Sci USA 72: 3925–3929.
Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C (1992): 9-Cis retinoic acid is high affinity ligand for the retinoid X receptor. Cell 68: 397–406.
Jensen EV, Suzuki T, Kawashima T, Stumpf WE, Jungblut PW and DeSombre ER (1968): A two step mechanism for the interaction of estradiol with rat uterus. Proc Natl Acad Sci USA 59: 632–638.
Jensen EV and DeSombre ER (1972): Mechanism of action of the female sex hormones. Annu Rev Biochem 41: 203–230.
Jowell PS, Epstein S, Fallon MD, Reinhardt TA and Ismail F (1987): 1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone gla protein and bone histomorphometry. Endocrinology 120: 531–536.
Johnston PF and McKnight SL (1989): Eukaryotic transcriptional regulatory proteins. Annu Rev Biochem 58: 799–839.
Kerner SA, Scott RA and Pike JW (1989): Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA 86: 4455–4459.
Kesterson RA, Stanley L, Finegold MJ, DeMayo F and Pike JW (1993): The human osteocalcin promoter directs bone-specific vitamin D-regulatable expression in transgenic mice. Mol Endo 7: 462–467.
Kliewer SA, Umesono K, Mangelsdorf DJ and Evans RM (1992): Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid honnone and vitamin D3 signalling. Nature 355: 446–449.
Kumar V and Chambon P (1988): The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145–156.
Leid M, Kastner P, Lyons R, Nakshatro H, Saunders M, Zacharewski T, Chen J-Y, Staub A, Garnier J-M, Mader S and Chambon P (1992): Purification, cloning, and RXR identity of the Hela cell Factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377–395.
Lian JB and Gundberg CM (1988): Osteocalcin: biochemical, considerations and clinical application. Clin Orthop Relat Res 226: 267–291.
Lian JB, Coutts MNC and Canalis E (1985): Studies of hormonal regulation of osteocalcin synthesis in cultured fetal rat calvariae. J Biol Chem 260: 8706–8710.
Lian JB, Carnes DL and Glimcher M (1987): Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats. Endocrinology 120: 2123–2130.
Lian JB, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collait D, Sambetti G and Stein G (1989): Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86: 1143–1147.
Liao J, Ozono K, Sone T, McDonnell DP and Pike JW (1990): Vitamin D receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 87: 9751–9755.
Malone JD, Teitelbaum SL, Griffin GL, Senior RM and Kahn AJ (1982): Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92: 227–230.
Mangelsdorf DJ, Ong ES, Dyck JA and Evans RM (1990): Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345: 224–229.
Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A and Evans RM (1992): Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Devel 6: 329–344.
Markose ER, Stein JL, Stein GS and Lian JB (1990): Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci USA 87: 1701–1705.
McDonnell DP, Scott RA, Kerner SA, O’Malley BW and Pike JW (1989). Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression. Mol Endo 3: 635–644.
McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR and O’Malley B W (1987): Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235: 1214–1217.
Morrison NA, Shine J, Fragonas J-C, Verkest V, McMenemy L and Eisman JA (1989): 1,25-Dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246: 1158–1161.
Nishimoto SK, Salka C and Nimni ME (1987): Retinoic acid and glucocorticoids enhance the effect of 1,25-dihydroxyvitamin D3 on bone-γ-carboxyglutamic acid protein synthesis by rat osteosarcoma cells. J Bone Mineral Res 2: 571–577.
Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF and Denhardt D (1990). Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Supp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87: 9995–9999.
O’Malley BW (1990): The steroid receptor superfamily: more excitement predicted for the future. Mol Endo 4: 363–369.
Ozono K, Liao J, Kerner SA, Scott RA and Pike JW (1990): The vitamin D responsive element in the human osteocalcin gene: association with a nuclear proto-oncogene enhancer. J Biol Chem 265: 21881–21888.
Ozono K, Sone T and Pike JW (1991): Functional interactions between vitamin D receptors and the AP-1 proto-oncogene family. J Bone Min Res 6, Suppl. 1, 677 (Abstr).
Pan LC and Price PA (1984): The effect of transcriptional inhibitors on the bone γ-carboxylic acid protein response to 1,25-dihydroxyvitamin D in osteosarcoma cells. J Biol Chem 259: 5844–5847.
Picard D and Yamamoto KR (1988): Two signals mediate hormone-dependent translocation of the glucocorticoid receptor. EMBO J 6: 3333–3340.
Pike JW (1990): Cis and trans regulation of osteocalcin gene expression by vitamin D and other hormones. In: Cohn, D.V., Glorieux, F.H., Martin, T. J, eds. Calcium Regulation and Bone Metabolism, vol 10, Excerpta Medica, Amsterdam, p. 127–136.
Price PA, Otsuka AS, Posner JW, Kristaponis J and Raman N (1976): Characterization of a γ-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci USA 73: 1447–1451.
Price PA and Nishimoto SK (1980): Radioimmunoassay for the vitamin D-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 77: 2234–23238.
Price PA, Parthemore JG and Deftos LF (1980): New biochemical marker for bone metabolism: measurement by radioimmunoassay of bone gla-protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 66: 878–883.
Price PA and Baukol SA (1980): 1,25-Dihydroxyvitamin D3 increases the synthesis of the vitamin D-dependent bone protein by osteosarcoma cells. J Biol Chem 255: 11660–11663.
Schule R, Umesono K, Mangelsdorf DJ, Bolado J, Pike JW and Evans RM (1990): Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61: 497–504.
Schwabe JWR, Neuhaus D and Rhodes D (1990): Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 348: 458–461.
Sone T, Scott RA, Hughes MR, Malloy PJ, Feldman D, O’Malley BW and Pike JW (1989): Mutant vitamin D receptors which confer hereditary resistance to 1,25-dihydroxyvitamin D3 in humans are transcriptionally inactive in vivo. J. Biol. Chem. 264: 20230–20234.
Sone T, McDonnell DP, O’Malley BW and Pike JW (1990): Expression of human vitamin D receptor in Saccharomyces cerevisiae: purification, properties, and generation of polyclonal antibodies. J Biol Chem 265: 21997–22003.
Sone T, Kerner SA and Pike JW (1991a): Vitamin D receptor interaction with specific DNA: association as a 1,25-dihydroxyvitamin D3-modulated heterodimer. J Biol Chem 266: 23296–23305.
Sone T, Ozono K and Pike JW (1991b). A 55 kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol Endo 5: 1578–1586.
Terpening CM, Haussler CA, Jurutka PW, Galligan MA, Komm BS and Haussler MR (1991): The vitamin D-responsive element in the rat bone gla protein gene is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3-mediated transcriptional activation. Mol Endo 5: 373–385.
Uchida M, Ozono K and Pike JW (1991): 24R,25-Dihydroxyvitamin D3 activates osteocalcin gene transcription through the vitamin D receptor. In: Norman, A. W., Bouillon, R., and Thomasset, M., eds. Vitamin D, gene regulation, structure-function analysis and clinical application, de Gruyter, Berlin, p 304–305.
Umesono K, Giguere V, Glass CK, Rosenfeld MG and Evans RM (1988): Retinolc acid and thyroid hormone induce gene expression through a common responsive element. Nature 336: 262–265.
Umesono K, Murikami KK, Thompson CC and Evans RM (1991): Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65: 1255–1266.
Yamamoto KR (1985): Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 19: 209–252.
Yoon D, Turledge SJC, Buenaga RF and Rodan GA (1988): Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3. Biochemistry 27: 8521–8526.
Yu V, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin J-M, Glass CK and Rosenfeld MG (1991): RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251–1266.
Zhang X-K, Hoffmann B, Tran PB-V, Graupner G and Pfahl M (1992): Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441–446.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Birkhäuser Boston
About this chapter
Cite this chapter
Pike, J.W. (1994). Insights into the Genomic Mechanism of Action of 1,25-Dihydroxyvitamin D3 . In: Moudgil, V.K. (eds) Steroid Hormone Receptors: Basic and Clinical Aspects. Hormones in Health and Disease. Birkhäuser Boston. https://doi.org/10.1007/978-1-4615-9849-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9849-7_6
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4615-9851-0
Online ISBN: 978-1-4615-9849-7
eBook Packages: Springer Book Archive